holmen lab banner

Lab News

Recent Publications

adobe-pdf-logo Akt signaling accelerates tumor recurrence following ras inhibition in the context of ink4a/arf loss.
Robinson GL, Robinson JP, Lastwika KJ, Holmen SL, VanBrocklin MW. (2013).
Genes Cancer 4(11-12):476-85.
adobe-pdf-logo IDH1 and IDH2 mutations in gliomas.
Cohen AL, Holmen SL, Colman H. (2013).
Curr Neurol Neurosci Rep 13(5):345.
adobe-pdf-logo Meeting report: The future of preclinical mouse models in melanoma treatment is now.
Merlino G, Flaherty K, Acquavella N, Day CP, Aplin A, Holmen S, Topalian S, Van Dyke T, Herlyn M. (2013).
Pigment Cell Melanoma Res 26(4):E8-E14.
adobe-pdf-logo Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions.
Jenkins NC, Jung J, Liu T, Wilde M, Holmen SL, Grossman D.
J Invest Dermatol 2013 Apr;133(4):1043-51.